ICHR

Business Context and Reporting Period

Company: Ichor Holdings, Ltd.
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Three months ended March 27, 2026 (Q1 2026)
Business Overview: Ichor designs, engineers, and manufactures critical fluid delivery subsystems and components primarily for semiconductor capital equipment, as well as defense/aerospace and medical industries. The company operates as a single business segment with a global footprint including facilities in the U.S., Singapore, Malaysia, and Mexico.

Key Financial Metrics

Note: Free Cash Flow Proxy calculated as Net Cash from Operating Activities plus Capital Expenditures.

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 4.7% to $256.1 million, driven by sustained demand in etch and deposition markets and increased semiconductor equipment spending.
• Profitability Improvement: The company returned to operating profitability ($2.1M income) compared to an operating loss of $1.2M in Q1 2025. Gross margin expanded 90 basis points to 12.6%, aided by higher factory utilization and the absence of $1.1M in severance charges that impacted the prior year.
• Net Loss Reduction: Net loss narrowed to $2.5M from $4.6M year-over-year. However, GAAP net loss was impacted by a significant income tax expense of $2.6M (effective rate 3,039.3%) due to the expiration of a Singapore tax holiday and valuation allowances on U.S. deferred tax assets.
• Working Capital: Operating cash flow turned negative ($2.9M used) compared to $19.0M provided in Q1 2025. This was primarily due to a $22.6M increase in accounts receivable and a $20.5M increase in inventory, partially offset by a $27.4M increase in accounts payable.
• Capital Expenditures: CapEx decreased significantly to $7.1M from $18.5M in the prior year.

Guidance, Outlook, and Risks

Management Commentary: Management notes robust demand in primary markets and continued momentum in semiconductor equipment spending. The company is executing a "Consolidation Restructuring Plan" to align its geographic footprint with long-term strategy, involving the transition of manufacturing activities to high-volume facilities.

Restructuring Plan Status: As of March 27, 2026, the plan includes expected costs for inventory impairment ($19.8M total, mostly recognized in 2025), fixed asset charges ($5.4M total), and lease impairments ($1.8M total). The plan is expected to be substantially complete by the end of 2026.

Risks and Contingencies:

• Tax Environment: The expiration of the Singapore tax holiday on March 31, 2026, has increased effective tax rates. The company is under examination by California tax authorities for fiscal years 2020-2022.
• Geopolitical and Trade: Risks include global trade volatility, potential new tariffs, and U.S. export controls restricting access to advanced semiconductor technology in China, which could disrupt supply chains and reduce demand.
• Customer Concentration: The company relies on a small number of original equipment manufacturers (OEMs) for a significant portion of sales.

Investor Verification Checklist

• Working Capital Trends: Verify the sustainability of the $22.6M increase in accounts receivable and $20.5M inventory build-up to ensure they align with sales growth and do not signal collection or obsolescence issues.
• Tax Rate Normalization: Assess the long-term impact of the Singapore tax holiday expiration on future effective tax rates and net income.
• Restructuring Execution: Monitor the remaining expected costs of the Consolidation Restructuring Plan (approx. $4.6M in fixed assets, leases, and other costs) and their impact on future cash flows.
• Debt Covenants: Confirm continued compliance with debt covenants under the amended credit agreement, particularly regarding leverage ratios based on trailing 12-month EBITDA.
• Non-GAAP Reconciliation: Review the reconciliation of Non-GAAP net income ($5.3M) to GAAP net loss ($2.5M) to understand the magnitude of adjustments for share-based compensation, amortization, and restructuring costs.